ClinicalTrials.gov
public full text
Public Domain
Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Therapy
The purpose of this study is to determine if IMC-11F8 is safe for patients, and also to determine the best dose of IMC-11F8 to give to patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of IMC-1121B in Patients With Advanced Solid Tumors#1096004
- A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors#871604
- Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab#912738
- A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors.#910786
- Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors#883688
Record · ID 992747
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive